FDA Inspection
Mark Stein, M.D.Mark Stein, M.D. – FDA Inspection, Jun 15, 2009
Record Details
This FDA Inspection record concerns Mark Stein, M.D., with an inspection on June 15, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Mark Stein, M.D.
- Inspection Date
- June 15, 2009
- Product Type
- Biologics
View Company Profile
ID · fb50b314-1d14-42e8-9848-bb0ccfd120ab
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 590927
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mark Stein, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2016 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Mark Stein, M.D.
- FDA Inspection 980723 - 2016-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.